48,830
edits
Line 7: | Line 7: | ||
| Micro = | | Micro = | ||
| Subtypes = (subtype of [[urothelial carcinoma]]) | | Subtypes = (subtype of [[urothelial carcinoma]]) | ||
| LMDDx = [[sarcoma]], [[carcinosarcoma]] - esp. in women, other sarcomatoid carcinomas | | LMDDx = [[sarcoma]], [[carcinosarcoma]] - esp. in women, other sarcomatoid carcinomas, [[collision tumour]] | ||
| Stains = | | Stains = | ||
| IHC = GATA +ve | | IHC = GATA +ve | ||
Line 33: | Line 33: | ||
==General== | ==General== | ||
*Rare.<ref name= | *Rare<ref name=pmid26068625/> approximately 0.1% of bladder carcinomas - based on the SEER database in the time span 1973-2004.<ref name=pmid20706685>{{Cite journal | last1 = Wang | first1 = J. | last2 = Wang | first2 = FW. | last3 = Lagrange | first3 = CA. | last4 = Hemstreet Iii | first4 = GP. | last5 = Kessinger | first5 = A. | title = Clinical features of sarcomatoid carcinoma (carcinosarcoma) of the urinary bladder: analysis of 221 cases. | journal = Sarcoma | volume = 2010 | issue = | pages = | month = | year = 2010 | doi = 10.1155/2010/454792 | PMID = 20706685 }}</ref> | ||
*Aggressive >55% dead within one year of presentation.<ref name=pmid26068625/> | *Aggressive >55% dead within one year of presentation.<ref name=pmid26068625/> | ||
edits